Other antineoplastic agents
Sub categories/Drugs:
- L01XX01: amsacrine
- L01XX02: asparaginase
- L01XX03: altretamine
- L01XX05: hydroxycarbamide
- L01XX07: lonidamine
- L01XX08: pentostatin
- L01XX10: masoprocol
- L01XX11: estramustine
- L01XX16: mitoguazone
- L01XX18: tiazofurine
- L01XX23: mitotane
- L01XX24: pegaspargase
- L01XX27: arsenic trioxide
- L01XX29: denileukin diftitox
- L01XX33: celecoxib
- L01XX35: anagrelide
- L01XX36: oblimersen
- L01XX37: sitimagene ceradenovec
- L01XX40: omacetaxine mepesuccinate
- L01XX41: eribulin
- L01XX44: aflibercept
- L01XX63: glasdegib
- L01XX64: entinostat
- L01XX65: alpelisib
- L01XX68: belotecan
- L01XX75: tebentafusp
- L01XX77: adagrasib
Description:
Clinical Syndromes:
Morphological Classes:
References:
NOTE: the following reference list is generated automatically and has not yet been verified.
Automatic PUBMED search: ("Other antineoplastic agents/adverse effects"[Mesh] OR "Other antineoplastic agents/toxicity"[Mesh]) AND (nephrotoxicity OR "Kidney Diseases/chemically induced"[Mesh] OR "Kidney Diseases/pathology"[Mesh] OR "Kidney Diseases/physiopathology"[Mesh])
loading references for 'Other antineoplastic agents' from pubmed ...
Case Reports: